From the AFR:
Charlie Shahin will invest $5.1 million into Vitura and become its third-largest shareholder. The funding will allow the company to acquire Candor Medical, which provides prescription treatments, including access to medicinal cannabis, through telehealth consultation.
There is a lot going on in a short space of time, if the management can hold it together, then there is significant up side for this company. The half year results will only show part of the picture but I'm keen to see them all the same. If nothing else the mind set of the Board and management has changed dramatically and they seem to have uncovered some very sound, profitable and connected businesses. Buckle in for the ride.
From the AFR:Charlie Shahin will invest $5.1 million into Vitura...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $45.69M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 63702 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 6000 | 1 |
View Market Depth
| Last trade - 09.59am 01/08/2025 (20 minute delay) ? |
| VIT (ASX) Chart |
Day chart unavailable